Beatriz Aguado

872 total citations
22 papers, 215 citations indexed

About

Beatriz Aguado is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Beatriz Aguado has authored 22 papers receiving a total of 215 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 7 papers in Oncology and 6 papers in Genetics. Recurrent topics in Beatriz Aguado's work include Multiple Myeloma Research and Treatments (11 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Cancer Treatment and Pharmacology (3 papers). Beatriz Aguado is often cited by papers focused on Multiple Myeloma Research and Treatments (11 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Cancer Treatment and Pharmacology (3 papers). Beatriz Aguado collaborates with scholars based in Spain, United States and Mexico. Beatriz Aguado's co-authors include Adrían Alegre, Rafael de la Cámara, Jesús F. San Miguel, Atanasio Pandiella, David P. Schenkein, Azucena Esparís‐Ogando, Albert Oriol, Joan Bladé, Norma C. Gutiérrez and Gema Mateo and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and International Journal of Cancer.

In The Last Decade

Beatriz Aguado

20 papers receiving 214 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Beatriz Aguado Spain 9 127 92 82 40 28 22 215
Sigrún Þorsteinsdóttir Denmark 7 96 0.8× 71 0.8× 79 1.0× 38 0.9× 32 1.1× 17 207
Bita Fakhri United States 11 118 0.9× 128 1.4× 69 0.8× 57 1.4× 20 0.7× 37 269
F. W. Cremer Germany 7 162 1.3× 140 1.5× 140 1.7× 50 1.3× 20 0.7× 11 295
Alessandra Cupri Italy 11 214 1.7× 76 0.8× 67 0.8× 88 2.2× 18 0.6× 27 313
Kenji Nara Japan 5 121 1.0× 102 1.1× 68 0.8× 35 0.9× 9 0.3× 5 170
Luděk Pour Czechia 8 61 0.5× 69 0.8× 79 1.0× 25 0.6× 16 0.6× 88 206
Victoria R. Alegria United States 8 105 0.8× 82 0.9× 73 0.9× 77 1.9× 16 0.6× 38 249
Chantiya Chanswangphuwana Thailand 8 104 0.8× 69 0.8× 36 0.4× 21 0.5× 14 0.5× 36 168
Peter Noellke Germany 6 128 1.0× 45 0.5× 75 0.9× 56 1.4× 18 0.6× 16 233
Arne Trummer Germany 9 108 0.9× 34 0.4× 116 1.4× 25 0.6× 19 0.7× 28 247

Countries citing papers authored by Beatriz Aguado

Since Specialization
Citations

This map shows the geographic impact of Beatriz Aguado's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beatriz Aguado with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beatriz Aguado more than expected).

Fields of papers citing papers by Beatriz Aguado

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beatriz Aguado. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beatriz Aguado. The network helps show where Beatriz Aguado may publish in the future.

Co-authorship network of co-authors of Beatriz Aguado

This figure shows the co-authorship network connecting the top 25 collaborators of Beatriz Aguado. A scholar is included among the top collaborators of Beatriz Aguado based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beatriz Aguado. Beatriz Aguado is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
León, Nieves Gómez, et al.. (2025). Whole-body MRI Versus [18F]FDG PET/CT in Diagnosing and Monitoring Plasmacytomas. Clinical Nuclear Medicine. 50(8). 695–706.
2.
Morgades, Mireia, Carlos Pinho Vaz, Rebeca Bailén, et al.. (2023). Prognosis of patients with acute lymphoblastic leukaemia relapsing after allogeneic stem cell transplantation. European Journal Of Haematology. 110(6). 659–668. 4 indexed citations
3.
León, Nieves Gómez, Beatriz Aguado, Adrían Alegre, et al.. (2021). Agreement Between 18F-FDG PET/CT and Whole-Body Magnetic Resonance Compared With Skeletal Survey for Initial Staging and Response at End-of-Treatment Evaluation of Patients With Multiple Myeloma. Clinical Nuclear Medicine. 46(4). 310–322. 14 indexed citations
4.
Bodega‐Mayor, Irene, Francisca Molina‐Jiménez, Martín González‐Andrade, et al.. (2020). TYK2 Variants in B-Acute Lymphoblastic Leukaemia. Genes. 11(12). 1434–1434. 7 indexed citations
5.
Cámara, Rafael de la, et al.. (2020). Can COVID‐19 cause severe neutropenia?. SHILAP Revista de lepidopterología. 8(12). 3348–3350. 18 indexed citations
6.
7.
Llamas‐Velasco, Mar, et al.. (2019). Cutaneous involvement as the first manifestation of T‐lymphoblastic lymphoma and review of the literature. Journal of Cutaneous Pathology. 46(5). 372–375. 7 indexed citations
8.
Arteche‐López, Ana, Anna Kreutzman, Adrían Alegre, et al.. (2017). Multiple myeloma patients in long-term complete response after autologous stem cell transplantation express a particular immune signature with potential prognostic implication. Bone Marrow Transplantation. 52(6). 832–838. 21 indexed citations
9.
Loscertales, Javier, et al.. (2016). Dynamics of Hemorragic Events and Primary Hemostasis Deffects during Treatment with Ibrutinib. Real-Life Experience. Blood. 128(22). 4936–4936. 1 indexed citations
10.
Alegre, Adrían, Albert Oriol, José García‐Laraña, et al.. (2012). Efficacy, safety and quality-of-life associated with lenalidomide plus dexamethasone for the treatment of relapsed or refractory multiple myeloma: the Spanish experience. Leukemia & lymphoma. 53(9). 1714–1721. 19 indexed citations
11.
Aguado, Beatriz, Felipe de Arriba, Anabel Teruel, et al.. (2012). Preliminary Experience of the Spanish Compassionate Use Registry of Bendamustine in Patients with Relapsed and/or Refractory Multiple Myeloma. Blood. 120(21). 4035–4035. 2 indexed citations
12.
Alegre, Adrían, et al.. (2011). Safety and Efficacy of Lenalidomide in Relapsed or Refractory Multiple Myeloma. Clinical Medicine Insights Oncology. 6. 1–10. 7 indexed citations
13.
Alegre, Adrían, Beatriz Aguado, Pilar Giraldo, et al.. (2011). Lenalidomide is effective as salvage therapy in refractory or relapsed multiple myeloma: analysis of the Spanish Compassionate Use Registry in advanced patients. International Journal of Hematology. 93(3). 351–360. 15 indexed citations
14.
Aguado, Beatriz, et al.. (2011). Extramedullary plasmacytomas in the context of multiple myeloma. Advances in Therapy. 28(S7). 7–13. 8 indexed citations
15.
Reyes, Guillermo, Keith B. Allen, Pablo Álvarez, et al.. (2010). Mid term results after bone marrow laser revascularization for treating refractory angina. BMC Cardiovascular Disorders. 10(1). 42–42. 11 indexed citations
16.
Reyes, Guillermo, Keith B. Allen, Beatriz Aguado, & Juan Duarte. (2009). Bone marrow laser revascularisation for treating refractory angina due to diffuse coronary heart disease☆. European Journal of Cardio-Thoracic Surgery. 36(1). 192–194. 5 indexed citations
17.
Alegre, Adrían, Beatriz Aguado, Juan José Lahuerta, et al.. (2007). Clinical Efficacy of Bortezomib Based Therapy in Plasma Cell Leukemias.. Blood. 110(11). 2726–2726. 1 indexed citations
18.
Gisbert, Javier P., Beatriz Aguado, Marta Luna, et al.. (2006). Gastric MALT lymphoma: clinical characteristics and prevalence of H. pylori infection in a series of 37 cases. Revista Española de Enfermedades Digestivas. 98(9). 655–65. 11 indexed citations
19.
García‐Noblejas, Ana, et al.. (2005). Pulmonary embolism in a patient with severe congenital deficiency for factor V during treatment with fresh frozen plasma. Haemophilia. 11(3). 276–279. 12 indexed citations
20.
Esparís‐Ogando, Azucena, Adrían Alegre, Beatriz Aguado, et al.. (2004). Bortezomib is an efficient agent in plasma cell leukemias. International Journal of Cancer. 114(4). 665–667. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sigrún Þorsteinsdóttir Breakdown of academic impact, for papers by Bita Fakhri Breakdown of academic impact, for papers by F. W. Cremer Breakdown of academic impact, for papers by Alessandra Cupri Breakdown of academic impact, for papers by Kenji Nara Breakdown of academic impact, for papers by Luděk Pour Breakdown of academic impact, for papers by Victoria R. Alegria Breakdown of academic impact, for papers by Chantiya Chanswangphuwana Breakdown of academic impact, for papers by Peter Noellke Breakdown of academic impact, for papers by Arne Trummer
Rankless by CCL
2026